- Home
- BIVI vs CYCU Comparison
BIVI vs CYCU Comparison
Compare BIVI & CYCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- CYCU
- Stock Information
- Founded
- BIVI 2013
- CYCU N/A
- Country
- BIVI United States
- CYCU United States
- Employees
- BIVI N/A
- CYCU N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- CYCU
- Sector
- BIVI Health Care
- CYCU
- Exchange
- BIVI Nasdaq
- CYCU Nasdaq
- Market Cap
- BIVI 15.0M
- CYCU 13.1M
- IPO Year
- BIVI N/A
- CYCU N/A
- Fundamental
- Price
- BIVI $1.60
- CYCU $0.32
- Analyst Decision
- BIVI
- CYCU
- Analyst Count
- BIVI 0
- CYCU 0
- Target Price
- BIVI N/A
- CYCU N/A
- AVG Volume (30 Days)
- BIVI 434.0K
- CYCU 24.3M
- Earning Date
- BIVI 08-15-2025
- CYCU 08-13-2025
- Dividend Yield
- BIVI N/A
- CYCU N/A
- EPS Growth
- BIVI N/A
- CYCU N/A
- EPS
- BIVI N/A
- CYCU N/A
- Revenue
- BIVI N/A
- CYCU $16,285,283.00
- Revenue This Year
- BIVI N/A
- CYCU N/A
- Revenue Next Year
- BIVI N/A
- CYCU N/A
- P/E Ratio
- BIVI N/A
- CYCU N/A
- Revenue Growth
- BIVI N/A
- CYCU N/A
- 52 Week Low
- BIVI $1.46
- CYCU $0.24
- 52 Week High
- BIVI $75.00
- CYCU $10.99
- Technical
- Relative Strength Index (RSI)
- BIVI 21.13
- CYCU N/A
- Support Level
- BIVI $1.46
- CYCU N/A
- Resistance Level
- BIVI $1.84
- CYCU N/A
- Average True Range (ATR)
- BIVI 0.40
- CYCU 0.00
- MACD
- BIVI 0.02
- CYCU 0.00
- Stochastic Oscillator
- BIVI 3.08
- CYCU 0.00
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About CYCU Cycurion Inc. Common Stock
Cycurion Inc. provides information technology security solutions through its subsidiaries. The Company continually strives to deliver top-notch services in risk management, cybersecurity, information assurance, systems engineering, and help desk solutions. The company generates the majority of its revenue from Advisory Consulting services, with small portion revenue generated from Managed Security Service Practice (MSSP) and Software as a Service (Saas).